Tenofovir disoproxil fumarate (TDF), marketed by Gilead Sciences under the trade name Viread®, belongs to a class of antiretroviral drugs known as nucleotide analogue reverse transcriptase inhibitors (NtRTIs), which block reverse transcriptase, an enzyme crucial to viral production in HIV-infected people.

Tenofovir is also available in a fixed-dose combination with emtricitabine in a product with the brand name Truvada® for once-a-day dosing. (Emtricitabine is marketed as a single-compound product called Emtriva®, also by Gilead.) A fixed-dose triple combination of tenofovir, emtricitabine and efavirenz (Sustiva®, marketed by Bristol-Myers Squibb) is in development.

Tenofovir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults. This indication is based on analyses of plasma HIV-1 RNA levels and CD4 cell counts in controlled studies of tenofovir in treatment-naïve and treatment-experienced adults. There are no study results demonstrating the effect of tenofovir on clinical progression of HIV.

More on [ Tenofovir ]

Tenofovir - Twitter Search

Vitamin D supplements benefit bone metabolism of younger patients taking tenofovir http://t.co/bluheKir #HIV
Ddrops (Ddrops Company) Sun, 29 Jan 2012 18:46:47 -0000
Vitamin D supplements benefit bone metabolism of younger patients taking tenofovir http://t.co/bluheKir #HIV
Emtricitabine/rilpivirine/tenofovir http://t.co/nSB7Yxbz [Like it? http://t.co/i9Z1cLu6 ]
khairull_a (• khairul anwar • ツ) Sun, 29 Jan 2012 13:17:23 -0000
Emtricitabine/rilpivirine/tenofovir http://t.co/nSB7Yxbz [Like it? http://t.co/i9Z1cLu6 ]
RT @LGTBNews: SALUD > Gilead inicia ensayo clínico un nuevo profármaco de baja dosis de tenofovir para el tratamiento del VIH http Subscribe to Tenofovir RSS feed